Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SARS-CoV-2 replication within host cells is critically dependent on a complex network of intracellular protein-protein interactions (PPIs) involving both viral and host proteins. These interactions orchestrate every stage of the viral life cycle, including entry, genome replication, transcription, translation, assembly, and egress. Disrupting these PPIs is a promising strategy for antiviral drug development. Key viral proteins involved include Nsps (especially nsp3/nsp4/nsp6/nsp9/nsp16) and structural protein N. Key host components include autophagy-related proteins (ATG5/LC3), Lamp2a, and Rab GTPases. These interactions are essential for membrane remodeling, DMV formation, translation control, and trafficking. Disruption of these interactions impairs essential steps in the virus life cycle.
Disruption/inhibition of viral-host protein interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular protein-protein interactions required for SARS-CoV-2 replication.